PRR15L 抗体 (AA 54-103)
Quick Overview for PRR15L 抗体 (AA 54-103) (ABIN6753641)
抗原
See all PRR15L 抗体适用
宿主
克隆类型
标记
应用范围
- 
    - 
                                            抗原表位
- AA 54-103
- 
                                            特异性
- Human ATAD4
- 
                                            纯化方法
- Immunoaffinity purified
- 
                                            免疫原
- 
                        Synthetic peptide from C-Terminus of human PRR15L (Q9BU68, NP_077296). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla, Gibbon, Monkey (100%).
 Type of Immunogen: Synthetic peptide
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- Optimal working dilution should be determined by the investigator.
- 
                                            说明
- 
                        Target Species of Antibody: Human 
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Lyophilized
- 
                                            溶解方式
- Distilled water
- 
                                            浓度
- Lot specific
- 
                                            缓冲液
- Lyophilized from PBS, 2 % sucrose.
- 
                                            储存条件
- 4 °C,-20 °C
- 
                                            储存方法
- 
                        Short term: 4°C
 Long term: -20°C.
 
- 
                                            
- 
    - PRR15L (Proline Rich 15-Like (PRR15L))
- 
                                            别名
- ATAD4
- 
                                            背景
- 
                        Name/Gene ID: PRR15L
 Synonyms: PRR15L, Protein ATAD4, ATAD4, Proline rich 15-like
- 
                                            基因ID
- 79170
- 
                                            NCBI登录号
- NP_077296
 抗原
- 
                    
 
                                     
                                     
                                    